Kaitlin Hicks
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: GlaxoSmithKline (United States) (2019)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Kaitlin Hicks' research focuses on the pharmaceutical sciences, specifically investigating factors that influence drug formulation and stability. Her work has examined the impact of counter ions on the saturation solubility of weak basic drugs, a critical consideration for developing stable, injectable solutions. This research aims to improve the physical stability and reduce hemolytic potential of drug formulations. Hicks has co-authored publications with Nicholas Callais and Ana Azevedo-Pouly from the University of Arkansas for Medical Sciences, indicating collaborative efforts within the institution. Her scholarly output includes a total of two publications, with her most recent appearing in 2026.
Metrics
- Publications: 2
Selected Publications
-
L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival (2026)
Collaboration Network
Top Collaborators
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
- L15. T Cell-Specific Loss of DNA-PKcs Enhances Allogeneic Cardiac Graft Survival
Similar Researchers
Based on overlapping research topics